Sandison Taylor

Average Profitability
18.64%
Insider Buys Quantity
2
Insider Buys Sum
$236,000.00
Insider Sells Quantity
5
Insider Sells Sum
$66,078.02

Insider Activity of Sandison Taylor

According to the SEC Form 4 filings, Sandison Taylor, being in a position of

  1. Chief Medical Officer at Cidara Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 21586 shares for $24,592,
    over all time since 2017-06-06, has bought 40000 shares for $236,000, and sold 66060 shares for $66,078.

The largest purchase of all time was on 2017-06-07 and amounted to 38688 shares of Cidara Therapeutics, Inc. for $228,259.

The largest sale of all time was on 2023-09-11 and amounted to 18793 shares of Cidara Therapeutics, Inc. for $17,810.

Biography of Sandison Taylor

No biography is available at this moment.

2024-09-11SaleCidara Therapeutics, Inc.
CDTX
Chief Medical Officer
924
0.0128%
$11.64$10,752+2.6%
2024-03-11SaleCidara Therapeutics, Inc.
CDTX
Chief Medical Officer
20,662
0.0231%
$0.67$13,839-4.43%
2023-09-11SaleCidara Therapeutics, Inc.
CDTX
Chief Medical Officer
18,793
0.0205%
$0.95$17,810-26.2%
2023-03-13SaleCidara Therapeutics, Inc.
CDTX
Chief Medical Officer
7,203
0.0081%
$1.53$11,021-45.66%
2022-09-12SaleCidara Therapeutics, Inc.
CDTX
Chief Medical Officer
18,478
0.0264%
$0.68$12,656+51.03%
2017-06-07PurchaseCidara Therapeutics, Inc.
CDTX
Chief Medical Officer
38,688
0.2298%
$5.90$228,259+18.64%
2017-06-06PurchaseCidara Therapeutics, Inc.
CDTX
Chief Medical Officer
1,312
0.0078%
$5.90$7,741+18.64%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.